INTRAVASCULAR PAPILLARY ENDOTHELIAL HYPERPLASIA

INTRAVASCULAR PAPILLARY ENDOTHELIAL HYPERPLASIA was reported 29 times

INTRAVASCULAR PAPILLARY ENDOTHELIAL HYPERPLASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Recombinant Human Growth Hormone [EPC] 3 0.0001
1 Atypical Antipsychotic [EPC] 9 0.0000
2 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
3 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
4 Leukocyte Growth Factor [EPC] 1 0.0000
5 Microtubule Inhibitor [EPC] 1 0.0000
6 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
7 RANK Ligand Inhibitor [EPC] 1 0.0000
8 Alkylating Drug [EPC] 1 0.0000
9 Corticosteroid [EPC] 5 0.0000
10 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
11 Kinase Inhibitor [EPC] 2 0.0000
12 Vitamin D [EPC] 1 0.0000
13 Vitamin B12 [EPC] 1 0.0000
14 Vitamin C [EPC] 1 0.0000
15 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
16 Tumor Necrosis Factor Blocker [EPC] 2 0.0000